Cargando…
Ceramide sphingolipid signaling mediates Tumor Necrosis Factor (TNF)-dependent toxicity via caspase signaling in dopaminergic neurons
BACKGROUND: Dopaminergic (DA) neurons in the ventral midbrain selectively degenerate in Parkinson’s disease (PD) in part because their oxidative environment in the substantia nigra (SN) may render them vulnerable to neuroinflammatory stimuli. Chronic inhibition of soluble Tumor Necrosis Factor (TNF)...
Autores principales: | Martinez, Terina N, Chen, Xi, Bandyopadhyay, Sibali, Merrill, Alfred H, Tansey, Malú G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3472284/ https://www.ncbi.nlm.nih.gov/pubmed/22973882 http://dx.doi.org/10.1186/1750-1326-7-45 |
Ejemplares similares
-
Neuroinflammation and tumor necrosis factor signaling in the pathophysiology of Alzheimer’s disease
por: McAlpine, Fiona E, et al.
Publicado: (2008) -
TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease
por: McCoy, Melissa K, et al.
Publicado: (2008) -
Apoptotic Sphingolipid Ceramide in Cancer Therapy
por: Huang, Wei-Ching, et al.
Publicado: (2011) -
Sphingolipids and ceramides in human aqueous humor
por: Aljohani, Ayman J., et al.
Publicado: (2013) -
The synthetic triterpenoid CDDO-methyl ester modulates microglial activities, inhibits TNF production, and provides dopaminergic neuroprotection
por: Tran, Thi A, et al.
Publicado: (2008)